Global Pandemicity of COVID-19: Situation Report as of June 9, 2020
Open accessAbstract
A novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, China in December 2019. This cluster quickly spread across the globe and led the World Health Organization (WHO) to declare severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) a pandemic on March 11, 2020. It’s sudden emergence, ceaseless human-to-human transmission, and rapid spread has led to continuous pandemicity. As of June 9, 2020, there were 7 039 918 confirmed cases and 404 396 deaths globally. The rate of spread of COVID-19 is affected through respiratory droplets, most commonly when infected individuals cough or talk. The virus is released through respiratory secretions that infect individuals once contact with mucous membranes is made directly or indirectly. Our research was conducted via an electronic literature review on PubMed, Google Scholar, and MedLine Plus. Data were then collected from peer-reviewed articles that included applicable keywords and published between January 1, 2020, and June 9, 2020. This article highlights the rapid spread of SARS-CoV-2 worldwide and indicates a higher number of mortalities in the elderly and those with comorbidities. As the number of cases increases, an immediate need to “flatten the curve” is essential to avoid catastrophic overwhelming of hospital systems across the affected countries. To do so, there is an emphasis on detection, testing, isolating the infected, and organizing the healthcare response to the virus. The rapid spread of infection has impacted over 200 countries and territories to date. This report takes a closer look at the cases, fatalities, and recoveries in different regions of the world with details regarding the geographic scale of SARS-CoV-2 spread, risks, and the subsequent impact on the countries affected. Also, this report discusses some effective measures that were carried out by some countries that helped them to mitigate the pandemic and flatten the curve of COVID-19 spread as early as possible.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The observation period 'during the pandemic' was not clearly defined beforehand because the beginning and end of the pandemic differed substantially between geographic regions.
“The observation period”
From Referral of patients to psychiatric emergency departments by police: A systematic review and meta-analysis (2025) · cites this paper as [24]
The Discussion says that geographic location and the timing of spread varied in their effects across countries, and the Introduction describes cases emerging in different regions at different times. Neither passage says that the pandemic’s beginning and end differed substantially by region or that an observation period could not be defined beforehand. Page numbers are not available in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Are high-performing health systems resilient against the COVID-19 epidemic?
Legido-Quigley, H., Asgari, N., Teo, Y. Y., Leung, G. M., Oshitani, H., Fukuda, K., Cook, A. R., Hsu, L. Y., Shibuya, K., & Heymann, D. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30551-1 · Cited by 563 · see citing works
Flagged first, then by citations
Research works printed but not linked: 15
- [2]The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020; 41(2): 145- 151. PMC8392929 34594836
- [3]Ralph R Lew J Zeng T, et al 2019-nCoV (Wuhan virus), a novel coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. J Infect Dev Ctries. 2020; 14: 3- 17. 32088679
- [4]Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventative Medicine Association. An update on the epidemiological characteristics of novel coronavirus pneumonia (COVID-19). Chin J Epidemiol. 2020; 41: 139- 144.
- [9]Cross J Summary of emergent infectious disease: coronavirus COVID-19 focus, compiled 19 March 2020. Presentation by Cross John W. 2020 Accessed April 30, 2020 https://www.researchgate.net/publication/340060965
- [10]Rabi FA Al Zoubi MS Kasasbeh GA Salameh DM Al-Nasser AD. SARS-CoV-2 and coronavirus disease 2019: what we know so far. Pathogens. 2020; 9: 231. PMC7157541 32245083
- [11]Cavallo JJ Donoho DA Forman HP Hospital capacity and operations in the coronavirus disease 2019 (COVID-19) pandemic—planning for the Nth patient. JAMA Health Forum. 3 17, 2020 Accessed April 30, 2020 https://jamanetwork.com/channels/health-forum/fullarticle/2763353 36218595
- [12]Le NK Le AV Parikh J, et al Ecological and health infrastructure factors affecting the transmission and mortality of COVID-19. BMC Infectious Diseases 3 30, 2020 Accessed April 30, 2020 10.21203/rs.3.rs-19504/v1 · DOI
- [13]Rodriguez AMJ Balbin GJR Rabaan A, et al Genomic epidemiology and its importance in the study of the COVID-19 pandemic. Infez Med. 2020; 28: 139- 142. 32275255
- [26]Villela DAM The value of mitigating epidemic peaks of COVID-19 for more effective public health responses. Rev Soc Bras Med Trop. 2020; 53: e20200135. 32215461 PMC7094046
- [27]Kenyon C. Flattening-the-curve associated with reduced COVID-19 case fatality rates—an ecological analysis of 65 countries. J Infect. 2020; 81: e98- e99. 32305488 PMC7162747
- [28]Shoukat A Wells CR Langley JM, et al Projecting demand for critical care beds during COVID-19 outbreaks in Canada. CMAJ. 2020; 192: E489- E496. 32269020 PMC7234264
- [34]Adalja AA Toner E Inglesby TV. Priorities for the US health community responding to COVID-19. JAMA. 2020; 323: 1342- 1344. 32125355
- [35]Zander-Jentsch B Wagner F Rzayeva N, et al Strengthening health systems through nursing: evidence from 14 European countries. European Observatory on Health Systems and Policies. 2019 Accessed June 6, 2020 https://pubmed.ncbi.nlm.nih.gov/31465161/ 31465161
- [36]Preskorn SH. The 5% of the population at high risk for severe COVID-19 infection is identifiable and needs to be taken into account when reopening the economy. J Psychiatr Pract. 2020; 26: 219- 227. 32421292 PMC7363378
- [37]Petersen E Wasserman S Lee S-S, et al COVID-19—we urgently need to start developing an exit strategy. Int J Infect Dis. 2020; 96: 233- 239. 32360552 PMC7188647
Cited by
Sorted by citations
Goldschmidt, T., Bermpohl, F., Schreiter, S., van Bergen, A. H., Kupka, R. W., Schouler-Ocak, M., Gutwinski, S., & Deutscher, K. (2025) · Psychiatric Services · doi:10.1176/appi.ps.20240323 · Cited by 2 · see citing works
- Authors
- Sanyaolu, A., Okorie, C., Hosein, Z., Patidar, R., Desai, P., Prakash, S., Jaferi, U., Mangat, J., & Marinkovic, A.
- Affiliations
- Federal Ministry of Health (NG)
- Essex County College (US)
- Caribbean Medical University School of Medicine, Curacao, Chicago, IL, USA
- Saint James School of Medicine, Anguilla (BWI), Park Ridge, IL, USA
- American University of Saint Vincent School of Medicine, Kingstown, St. Vincent and the Grenadines
- All Saints University School of Medicine (DM)
- Corresponding author
- Sanyaolu, Adekunle
- ORCID
- Venue
- Infectious Diseases: Research and Treatment
- Publisher
- SAGE Publications
- Published
- 2021-01
- Volume
- 14
- Pages
- 1178633721991260-1178633721991260
- ISSN
- 1178-6337 (ISSN-L)
- PMC
- PMC7863149
- OpenAlex
- W3126240380
- Cited by
- 79
- References
- 1
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 14 · 2023: 26 · 2022: 21 · 2021: 11
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Infectious Diseases Research and Treatment (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (acceptedVersion)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, pandemic spread, respiratory droplet transmission, flattening the curve, health system capacity, infection control measures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
